Correlation Between Evertz Technologies and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Evertz Technologies and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evertz Technologies and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evertz Technologies Limited and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Evertz Technologies and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evertz Technologies with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evertz Technologies and Tarsus Pharmaceuticals.

Diversification Opportunities for Evertz Technologies and Tarsus Pharmaceuticals

0.3

Correlation Coefficient

Evertz Technologies  Tarsus Pharmaceuticals

Weak diversification

The 3 months correlation between Evertz and Tarsus is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Evertz Technologies Limited and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Evertz Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evertz Technologies Limited are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Evertz Technologies i.e., Evertz Technologies and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Evertz Technologies and Tarsus Pharmaceuticals

Assuming the 90 days horizon Evertz Technologies Limited is expected to under-perform the Tarsus Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Evertz Technologies Limited is 1.77 times less risky than Tarsus Pharmaceuticals. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  5,435  in Tarsus Pharmaceuticals on December 25, 2024 and sell it today you would lose (273.50) from holding Tarsus Pharmaceuticals or give up 5.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	96.77%
Values	Daily Returns

Evertz Technologies Limited  vs.  Tarsus Pharmaceuticals

Evertz Technologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Evertz Technologies Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tarsus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Tarsus Pharmaceuticals is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Evertz Technologies and Tarsus Pharmaceuticals

The main advantage of trading using opposite Evertz Technologies and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evertz Technologies position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind Evertz Technologies Limited and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..